In the Chinese city of Wuhan, the wet market that spawned the pandemic which has brought the world to its knees now slumbers quietly behind a tidy-looking blue-and-white partition. But there are ample ...
BioWorld - Tuesday, September 30, 2025 See today's BioWorld Home » Wuhan Healthgen gets chance at China IPO with SSE market reforms To read the full story, subscribe or sign in.
Health authorities in Wuhan, China, issued an urgent alert reporting cases of an unidentified pneumonia. It initially went ...
TipRanks on MSN
Wuhan YZY Biopharma wins NMPA IND nod for Hemlibra biosimilar Y225 and deepens antibody R&D push
Wuhan YZY Biopharma Co., Ltd. Class H ( ($HK:2496) ) has issued an update. Wuhan YZY Biopharma has received Investigational New Drug approval from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback